2022
Next-generation sequencing in children with epilepsy: The importance of precise genotype–phenotype correlation
HORÁK, Ondřej; Martina BUREŠOVÁ; Senad KOLÁŘ; Klára ŠPANĚLOVÁ; Barbora JEŘÁBKOVÁ et. al.Základní údaje
Originální název
Next-generation sequencing in children with epilepsy: The importance of precise genotype–phenotype correlation
Autoři
HORÁK, Ondřej; Martina BUREŠOVÁ; Senad KOLÁŘ; Klára ŠPANĚLOVÁ; Barbora JEŘÁBKOVÁ; Renata GAILLYOVÁ; Katarína ČESKÁ; Kamila RÉBLOVÁ ORCID; Jana ŠOUKALOVÁ; Jana ZÍDKOVÁ ORCID; Lenka FAJKUSOVÁ; Hana OŠLEJŠKOVÁ; Ivan REKTOR a Pavlína DANHOFER
Vydání
EPILEPSY & BEHAVIOR, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2022, 1525-5050
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.600
Kód RIV
RIV/00216224:14110/22:00126826
Organizační jednotka
Lékařská fakulta
UT WoS
000761035600024
EID Scopus
2-s2.0-85122932096
Klíčová slova anglicky
Epilepsy; Genetic testing; Children; Next-generation sequencing; Precise medicine
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 8. 2025 08:48, Mgr. Eva Dubská
Anotace
V originále
Aim: The primary goal was to determine the yield of next-generation sequencing (NGS) epilepsy gene panels used for epilepsy etiology diagnosing using a multidisciplinary approach and to demonstrate the importance of genotype-phenotype correlations. The secondary goal was to evaluate the application of precision medicine in selected patients. Methods: This single-center retrospective study included a total of 175 patients (95 males and 80 females) aged 0-19 years. They were examined between 2015 and 2020 using an NGS epilepsy gene panel (270 genes). A bioinformatic analysis was performed including copy number variation identifica-tion. Thorough genotype-phenotype correlation was performed. Results: Out of 175 patients, described pathogenic variants or novel variants with clear pathogenic impact were identified in 30 patients (17.14%). Genotype-phenotype correlations and parental DNA anal-ysis were performed, and genetic diagnosis was confirmed on the basis of the results in another 16 out of 175 patients (9.14%). The diagnostic yield of our study increased from 30 to 46 patients (by 53.33%) by the precise genotype-phenotype correlation. Interpretation: We emphasize a complex genotype-phenotype correlation and a multidisciplinary approach in evaluating the results of the NGS epilepsy gene panel, which enables the most accurate genetic diagnosis and correct interpretation of results.
Návaznosti
| ROZV/28/LF6/2020, interní kód MU |
|